Article info

Download PDFPDF

Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’’ by Wang et al
Free

Authors

  • Renaud Felten Service de Rhumatologie, CHU de Strasbourg, Centre National de Référence pour les Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest RESO, Hôpitaux universitaires de Strasbourg, Strasbourg, France IBMC, CNRS, UPR3572, Université de Strasbourg, Strasbourg, Alsace, France PubMed articlesGoogle scholar articles
  • Jacques-Eric Gottenberg Service de Rhumatologie, CHU de Strasbourg, Centre National de Référence pour les Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest RESO, Hôpitaux universitaires de Strasbourg, Strasbourg, France IBMC, CNRS, UPR3572, Université de Strasbourg, Strasbourg, Alsace, France PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Jacques-Eric Gottenberg, Service de Rhumatologie, CHU de Strasbourg, Centre National de Référence pour les Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest RESO, Hôpitaux universitaires de Strasbourg, Strasbourg, Alsace, France; jacques-eric.gottenberg{at}chru-strasbourg.fr
View Full Text

Citation

Felten R, Gottenberg J
Response to: ‘Correspondence on ‘Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial’’ by Wang et al

Publication history

  • Received January 11, 2021
  • Accepted January 12, 2021
  • First published January 27, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.